One Of The Factors Driving The Growth Of The Next Generation Sequencing Market During The Forecast Period Is The Increasing Prevalence Of Chronic Medical Ailments

 

Next Generation Sequencing

Next-generation sequencing (NGS) is a massively parallel sequencing technology that provides scalability, ultra-high throughput, and high speed in determining the order of nucleotides across the entire genome. As it involves preparing the sample for the subsequent sequencing reaction, DNA pre-sequencing is one of the most important steps in the overall sequencing protocol. Globally, NGS is increasingly being integrated into clinical laboratory analysis, testing, and disease diagnostics in the healthcare sector. NGS has been widely used in pharmacogenomics to speed up drug discovery. The global next generation sequencing market is being driven primarily by an increase in genome mapping programmes, an increase in next generation sequencing applications, an increase in healthcare expenditure, and technological advancements in sequencing platforms. For example, in 2019, Thermo Fisher Scientific, a global leader in science service, launched the Ion Torrent Genexus System, a next-generation platform that delivers the specimen to report in a single step.

 

One of the factors driving the growth of the Next Generation Sequencing Market during the forecast period is the increasing prevalence of chronic medical ailments such as cancer in the field of medical sciences, as well as numerous technological advancements. The widespread use of liquid biopsies in cancer diagnostics has resulted in a significant increase in the use of NGS technologies. For example, according to the World Health Organization, on March 3rd, 2021, cancer will be a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. Worldwide, there are approximately 2.26 million breast cancer cases, 2.21 million lung cancer cases, nearly 1.41 million prostate cancer cases, and 1.09 million stomach cancer cases. Next-generation sequencing aids in the collection of a massive amount of genomic information about cancer. When compared to traditional methods, NGS provides greater accuracy and sensitivity.

 

Furthermore, expanding genome mapping programmes are another factor that is likely to accelerate the growth of the next-generation sequencing market. For example, the Department of Biotechnology (DBT) launched the impressive "Genome India Project" on January 3rd, 2020. (GIP). The GIP aims to collect over 10,000 genetic samples from Indian citizens in order to create a reference genome. UK government projects managed by genomics England completed nearly 100,000 genome projects. The demand for next-generation sequencing is being fueled by a number of outstanding programmes and projects around the world.

Comments

Popular posts from this blog

Vascular Ulcers Treatment focuses on keeping the wound site free of infection during the healing process and relieving edema

Hearing Protection Devices: Often Used To Prevent Noise-Induced Hearing Loss (NIHL)

Electric Wheelchair Market Size, Share, Outlook, and Opportunity Analysis, 2021 – 2028